These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 35326714)
1. Metabolic Profiling of Thymic Epithelial Tumors Hints to a Strong Warburg Effect, Glutaminolysis and Precarious Redox Homeostasis as Potential Therapeutic Targets. Alwahsh M; Knitsch R; Marchan R; Lambert J; Hoerner C; Zhang X; Schalke B; Lee DH; Bulut E; Graeter T; Ott G; Kurz KS; Preissler G; Schölch S; Farhat J; Yao Z; Sticht C; Ströbel P; Hergenröder R; Marx A; Belharazem D Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326714 [TBL] [Abstract][Full Text] [Related]
2. Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets. Shimada M; Taniguchi H; Yamaguchi H; Gyotoku H; Sasaki D; Kaku N; Senju C; Senju H; Imamura E; Takemoto S; Yamamoto K; Sakamoto N; Obase Y; Tsuchiya T; Fukuda M; Soda H; Ashizawa K; Fukuoka J; Nagayasu T; Yanagihara K; Mukae H Transl Lung Cancer Res; 2023 Apr; 12(4):707-718. PubMed ID: 37197618 [TBL] [Abstract][Full Text] [Related]
3. Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors. Xu S; Li X; Zhang H; Zu L; Yang L; Shi T; Zhu S; Lei X; Song Z; Chen J Front Oncol; 2021; 11():667148. PubMed ID: 34307137 [TBL] [Abstract][Full Text] [Related]
4. Programmed death-ligand 1 expression profiling in thymic epithelial cell tumors: Clinicopathological features and quantitative digital image analyses. Ishihara S; Okada S; Ogi H; Kodama Y; Shimomura M; Tsunezuka H; Itoh K; Marx A; Inoue M Lung Cancer; 2020 Jul; 145():40-47. PubMed ID: 32402921 [TBL] [Abstract][Full Text] [Related]
5. Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients. Liang N; Liu L; Huang C; Liu H; Guo C; Li J; Wang W; Li N; Lin R; Wang T; Ding L; Mao L; Li S Front Oncol; 2021; 11():647512. PubMed ID: 34568003 [TBL] [Abstract][Full Text] [Related]
7. Brief Report: High Levels of CD47 Expression in Thymic Epithelial Tumors. Sun TY; Nguyen B; Chen SB; Natkunam Y; Padda S; van de Rijn M; West R; Neal JW; Wakelee H; Riess JW JTO Clin Res Rep; 2023 Apr; 4(4):100498. PubMed ID: 37020927 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Prognostic Significances of SOX9 in Thymic Epithelial Tumor. Yuan X; Huang L; Luo W; Zhao Y; Nashan B; Yu F; Liu Y Front Oncol; 2021; 11():708735. PubMed ID: 34778027 [TBL] [Abstract][Full Text] [Related]
9. Thymic Epithelial Tumors: An Evolving Field. Kuhn E; Pescia C; Mendogni P; Nosotti M; Ferrero S Life (Basel); 2023 Jan; 13(2):. PubMed ID: 36836670 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors. Song JS; Kim D; Kwon JH; Kim HR; Choi CM; Jang SJ Front Oncol; 2019; 9():1055. PubMed ID: 31681591 [No Abstract] [Full Text] [Related]
11. Analysis of the tumor microenvironment and mutation burden identifies prognostic features in thymic epithelial tumors. Hou X; Lin S; Liu Y; Wang K; Yu Z; Jia J; Yu J; Zheng W; Bai J; Chang L; Chen J; Li M; Chen L Am J Cancer Res; 2022; 12(5):2387-2396. PubMed ID: 35693087 [TBL] [Abstract][Full Text] [Related]
12. Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors. Arbour KC; Naidoo J; Steele KE; Ni A; Moreira AL; Rekhtman N; Robbins PB; Karakunnel J; Rimner A; Huang J; Riely GJ; Hellmann MD PLoS One; 2017; 12(8):e0182665. PubMed ID: 28771603 [TBL] [Abstract][Full Text] [Related]
13. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets. Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328 [TBL] [Abstract][Full Text] [Related]
15. Immunotherapy in thymic epithelial tumors: tissue predictive biomarkers for immune checkpoint inhibitors. Lucà S; Accardo M; Campione S; Franco R Explor Target Antitumor Ther; 2024; 5(3):465-476. PubMed ID: 38966177 [TBL] [Abstract][Full Text] [Related]
16. Discovery and validation of DNA methylation markers for overall survival prognosis in patients with thymic epithelial tumors. Li S; Yuan Y; Xiao H; Dai J; Ye Y; Zhang Q; Zhang Z; Jiang Y; Luo J; Hu J; Chen C; Wang G Clin Epigenetics; 2019 Mar; 11(1):38. PubMed ID: 30832724 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors. Meurgey A; Girard N; Merveilleux du Vignaux C; Maury JM; Tronc F; Thivolet-Bejui F; Chalabreysse L J Thorac Oncol; 2017 Oct; 12(10):1571-1581. PubMed ID: 28694035 [TBL] [Abstract][Full Text] [Related]
18. Prognostic and immunological significance of metastasis-associated protein 3 in patients with thymic epithelial tumors. Li J; Deng Z; Liu Y; Jin J; Xie C; Gan J Discov Oncol; 2024 Jun; 15(1):216. PubMed ID: 38852126 [TBL] [Abstract][Full Text] [Related]
19. Incidence and clinical variable inter-relationships of thymic epithelial tumors in northwest China. Feng XL; Lei XB; Dong WT; Yan LF; Xin YK; Li GF; Jing Y; Duan SJ; Zhang J; Hu YC; Li B; Zhao SS; Sun Q; Zhang J; Zhang T; Cheng DL; Cui GB; Wang W J Thorac Dis; 2018 Dec; 10(12):6794-6802. PubMed ID: 30746224 [TBL] [Abstract][Full Text] [Related]
20. Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in Szpechcinski A; Szolkowska M; Winiarski S; Lechowicz U; Wisniewski P; Knetki-Wroblewska M Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]